Knisely, A. T., Michaels, A. D., Mehaffey, J. H., Hassinger, T. E., Krebs, E. D., Brenin, D. R., … Showalter, S. L. (2018). Race is associated with completion of neoadjuvant chemotherapy for breast cancer. Surgery, 164(2), 195–200. https://doi.org/10.1016/j.surg.2018.03.011

Knisely, Anne T., Alex D. Michaels, J Hunter Mehaffey, Taryn E. Hassinger, Elizabeth D. Krebs, David R. Brenin, Anneke T. Schroen, and Shayna L. Showalter. “Race is associated with completion of neoadjuvant chemotherapy for breast cancer.” Surgery 164, no. 2 (August 2018): 195–200. https://doi.org/10.1016/j.surg.2018.03.011.

Knisely AT, Michaels AD, Mehaffey JH, Hassinger TE, Krebs ED, Brenin DR, et al. Race is associated with completion of neoadjuvant chemotherapy for breast cancer. Surgery. 2018 Aug;164(2):195–200.

Knisely, Anne T., et al. “Race is associated with completion of neoadjuvant chemotherapy for breast cancer.” Surgery, vol. 164, no. 2, Elsevier BV, Aug. 2018, pp. 195–200. Crossref, doi:10.1016/j.surg.2018.03.011.

Knisely AT, Michaels AD, Mehaffey JH, Hassinger TE, Krebs ED, Brenin DR, Schroen AT, Showalter SL. Race is associated with completion of neoadjuvant chemotherapy for breast cancer. Surgery. Elsevier BV; 2018 Aug;164(2):195–200.